Clinical Trials Browser

Phase 4 × Unknown × Antineoplastic Agents × Clear all

NCT03799679 2019-01-10

Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer

Phase 4 Unknown

Triple Negative Breast Neoplasms

NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Phase 4 Unknown

Neoplasms, Neoplasms, Second Primary